Pieris Pharmaceuticals - Pre-Merger Palvella Stockholders Will Own Approximately 82% of Combined Company on a Pro Forma Basis
合併前,Palvella的股東將基於實際情況佔據合併後公司的約82%的股份。-pieris pharmaceuticals
Pieris Pharmaceuticals - Pre-Merger Palvella Stockholders Will Own Approximately 82% of Combined Company on a Pro Forma Basis
合併前,Palvella的股東將基於實際情況佔據合併後公司的約82%的股份。-pieris pharmaceuticals
譯文內容由第三人軟體翻譯。